06.02.15
Jeffrey Bagshaw has been appointed vice president of global business development for the Clinical Trials Division at TKL Research. Mr. Bagshaw will be responsible for leading international strategic corporate and business development efforts.
Mr. Bagshaw has more than 25 years of experience in the pharma, biopharma, medical device and applied genomic industries. Previously, he served as chief operating officer at Inclinix, Inc., where he was responsible for leading global operations, strategic partnership development and clinical research services. He also held various leadership roles at Inclinix in medical marketing and compliance, medical support services and business development.Additional experience includes leadership roles at Hoffmann-La Roche, Bristol-Myers Squibb and Exact Sciences.
“Jeff is a proven leader in business development and clinical operations,” said Dr. Robert Reardon, Ph.D., chief operating officer at TKL. “This unique combination gives him an exceptional ability to understand client needs and will help us tailor our offerings for rapid enrollment and high-quality clinical research.”
Mr. Bagshaw has more than 25 years of experience in the pharma, biopharma, medical device and applied genomic industries. Previously, he served as chief operating officer at Inclinix, Inc., where he was responsible for leading global operations, strategic partnership development and clinical research services. He also held various leadership roles at Inclinix in medical marketing and compliance, medical support services and business development.Additional experience includes leadership roles at Hoffmann-La Roche, Bristol-Myers Squibb and Exact Sciences.
“Jeff is a proven leader in business development and clinical operations,” said Dr. Robert Reardon, Ph.D., chief operating officer at TKL. “This unique combination gives him an exceptional ability to understand client needs and will help us tailor our offerings for rapid enrollment and high-quality clinical research.”